entacapone

Related to entacapone: amantadine, pramipexole, Selegiline

Translations

entacapone

n entacapona

References in periodicals archive ?

In June 2003, Orion Pharma received the Marketing Authorization from FDA for Stalevo, a new treatment of PD, which combines levodopa and carbidopa with entacapone in one tablet.

JURILAB LAUNCHES NEW DRUG METABOLISM ENZYME TEST

Other helpful drugs for response fluctuations include "COMT inhibitors" such as entacapone, as well as Eldepryl and amantadine.

MICHAEL J. FOX'S CHALLENGING NEW ROLE

Conversely, market growth will be constrained through 2021 by the increased uptake of generic versions of ropinirole (both immediate- and controlled-release formulations) and pramipexole (both immediate- and extended-release formulations), as well as the entrance of generic versions of other prominent Parkinson's disease agents, entacapone (Novartis/Orion Pharma's Comtan/Comtess/Stalevo, generics) and Teva/Lundbeck's Azilect/Agilect.

Most Sales in the Parkinson's Disease Drug Market Will Continue to Be Driven by the Leading Dopamine Agonists Pramipexole and Ropinirole Coupled with the Reentry of UCB's Neupro/Leganto to the U.S. Market

open-house-model" in the period from 15/04/2016 to 03/31/2018 for medicines for drug entacapone (atc code by who : n04bx02).

Pharmaceutical Products

The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's disease.

Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's Disease

Wockhardt USA's recent approvals include: clarithromycin IR tablets, fluticasone nasal spray, valacyclovir HCI caplets, carbidopa, entacapone, levodopa oral tablets and alfuzosine HCI ER tablets.

Wockhardt USA

Adding a cathecol-O-methyltransferase (COMT) inhibitor, such as entacapone, to increase levodopa's effectiveness has been shown to reduce motor fluctuations (2,3,10) (SOR: B).

How best to address these common movement disorders: this review describes how to manage everything from Parkinson's disease and tic disorders to restless legs syndrome and ataxia

ASCEND-PD is a multinational Phase III comparative study of IPX066 to carbidopa-levodopa and entacapone in subjects with advanced PD.

Impax completes enrollment in ASCEND-PD Phase III study of IPX066 in Parkinson's disease

The effect of entacapone on decreasing plasma Hcy levels is still controversial.

Effect of L-dopa therapy on plasma homocysteine levels and, consequently, on carotid intima-media thickness in Parkinson's disease patients/Parkinson hastalarinda L-dopa tedavisinin, plazma homosistein duzeyleri ve bununla iliskili karotis intima-media kalinliklari uzerine olan etkisi

The FDA is continuing to review the cardiovascular safety of Stalevo, a three-drug-in-one pill for Parkinson's disease, after completing a meta-analysis that failed to resolve the issue of whether adding entacapone to a carbidopa/levodopa combination increases cardiovascular risk, the agency announced last month.

Parkinson drug's safety questioned

An excess number of prostate cancer cases among men treated with the Parkinson's disease product that contains entacapone, carbidopa, and levodopa in a controlled clinical trial has prompted an FDA review of the combination drug's safety.

Cancer linked with Parkinson's Rx

carbidopa/levodopa and entacapone previously administered as individual products and to replace immediate-release